Progressive Myoclonus Epilepsy: A Scoping Review of Diagnostic, Phenotypic and Therapeutic Advances

V Zimmern, B Minassian - Genes, 2024 - mdpi.com
The progressive myoclonus epilepsies (PME) are a diverse group of disorders that feature
both myoclonus and seizures that worsen gradually over a variable timeframe. While each of …

Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease

G d'Orsi, A Farolfi, L Muccioli, O Palumbo… - Frontiers in …, 2023 - frontiersin.org
Purpose To evaluate the electro-clinical features in association with laboratory and
instrumental correlates of neurodegeneration to detect the progression of Lafora disease …

[HTML][HTML] Lafora disease

F Ibrahim, NI Murr - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Objectives: Identify the clinical presentation and characteristic symptoms of Lafora disease.
Differentiate Lafora disease from other forms of progressive myoclonic epilepsy. Select …

Retinal Phenotyping of a Murine Model of Lafora Disease

A Vincent, K Ahmed, R Hussein, Z Berberovic… - Genes, 2023 - mdpi.com
Lafora disease (LD) is a progressive neurologic disorder caused by biallelic pathogenic
variants in EPM2A or EPM2B, leading to tissue accumulation of polyglucosan aggregates …